Thermo Fisher Scientific
Stock Forecast, Prediction & Price Target
Thermo Fisher Scientific (TMO) stock Price Target by analysts
$637.38
Potential upside: 28.95%
Thermo Fisher Scientific price prediction
What is Thermo Fisher Scientific stock analysts` prediction?
Thermo Fisher Scientific stock forecast: Based on 7 Wall Street analysts` predicted price targets for Thermo Fisher Scientific in the last 3 months, the avarage price target is $637.38, with a high forecast of $NaN. The average price target represents a 28.95% change from the last price of $494.25.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Thermo Fisher Scientific stock Price Target by analysts
Full breakdown of analysts given Thermo Fisher Scientific price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Catherine Schulte Robert W. Baird | 0% 0/3 | 11 months ago | $622 25.84% upside | $576.49 | StreetInsider | Previous targets (2) |
Luke Sergott Barclays | 0% 0/4 | 11 months ago | $610 23.41% upside | $570.92 | TheFly | Previous targets (3) |
Vijay Kumar Evercore ISI | 0% 0/1 | 12 months ago | $630 27.46% upside | $618.57 | TheFly | Previous targets (0) |
Daniel Arias Stifel Nicolaus | 0% 0/1 | 12 months ago | $680 37.58% upside | $620.25 | StreetInsider | Previous targets (0) |
Catherine Schulte Robert W. Baird | 0% 0/3 | 12 months ago | $632 27.87% upside | $620.25 | StreetInsider | Previous targets (2) |
Patrick Donnelly Citigroup | 0% 0/1 | 12 months ago | $620 25.44% upside | $617.11 | StreetInsider | Previous targets (0) |
Justin Bowers Deutsche Bank | 0% 0/2 | 12 months ago | $630 27.46% upside | $609.41 | StreetInsider | Previous targets (1) |
Derik de Bruin Bank of America Securities | 0% 0/2 | about 1 year ago | $675 36.57% upside | $611.17 | StreetInsider | Previous targets (1) |
Andrew Cooper Raymond James | 50% 1/2 | about 1 year ago | $660 33.53% upside | $593.86 | TheFly | Previous targets (1) |
Luke Sergott Barclays | 0% 0/4 | about 1 year ago | $600 21.39% upside | $550.78 | TheFly | Previous targets (3) |
Sidharth Sahoo HSBC | 0% 0/1 | over 1 year ago | $670 35.55% upside | $576.89 | TheFly | Previous targets (0) |
Luke Sergott Barclays | 0% 0/4 | over 1 year ago | $615 24.43% upside | $577.39 | TheFly | Previous targets (3) |
Justin Bowers Deutsche Bank | 0% 0/2 | over 1 year ago | $610 23.41% upside | $577.39 | StreetInsider | Previous targets (1) |
Catherine Schulte Robert W. Baird | 0% 0/3 | over 1 year ago | $670 35.55% upside | $531.65 | Benzinga | Previous targets (2) |
Andrew Cooper Raymond James | 50% 1/2 | almost 2 years ago | $530 7.23% upside | $444.46 | Benzinga | Previous targets (1) |
Thermo Fisher Credit Suisse | 0% 0/1 | about 2 years ago | $620 25.44% upside | $525.63 | Benzinga | Previous targets (0) |
Unknown Leerink Partners | N/A | over 2 years ago | $630 27.46% upside | $587.36 | Benzinga | N/A |
Unknown Leerink Partners | N/A | over 2 years ago | $620 25.44% upside | $532.88 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 2 years ago | $505 2.17% upside | $553.18 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | almost 3 years ago | $620 25.44% upside | $571.38 | Benzinga | N/A |
Unknown RBC Capital | N/A | almost 3 years ago | $661 33.73% upside | $550.53 | Benzinga | N/A |
Unknown Barclays | N/A | almost 3 years ago | $570 15.32% upside | $540.03 | Benzinga | N/A |
Unknown Barclays | N/A | about 3 years ago | $595 20.38% upside | $569.4 | Benzinga | N/A |
Luke Sergott Barclays | 0% 0/4 | about 3 years ago | $685 38.59% upside | $587.98 | Pulse 2.0 | Previous targets (3) |
Unknown Barclays | N/A | about 3 years ago | $685 38.59% upside | $598.41 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $650 31.51% upside | $597.64 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $678 37.17% upside | $606.24 | Benzinga | N/A |
Unknown Barclays | N/A | about 3 years ago | $630 27.46% upside | $530.93 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 3 years ago | $670 35.55% upside | $563.79 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $525 6.22% upside | $561.28 | Benzinga | N/A |
Tejas Savant Morgan Stanley | 0% 0/1 | almost 4 years ago | $700 41.62% upside | $619.47 | TheFly | Previous targets (0) |
Robert Wasserman Benchmark Co. | 100% 1/1 | almost 4 years ago | $650 31.51% upside | $611.7 | MarketWatch | Previous targets (0) |
Matthew Sykes Goldman Sachs | 0% 0/1 | almost 4 years ago | $690 39.60% upside | $607.64 | TheFly | Previous targets (0) |
Brandon Couillard Jefferies | 100% 1/1 | almost 4 years ago | $540 9.25% upside | $589.63 | TipRanks | Previous targets (0) |
Derik de Bruin Bank of America Securities | 0% 0/2 | almost 4 years ago | $670 35.55% upside | $589.63 | StreetInsider | Previous targets (1) |
Tycho Peterson J.P. Morgan | 0% 0/1 | almost 4 years ago | $700 41.62% upside | $589.63 | TheFly | Previous targets (0) |
Paul Knight KeyBanc | 0% 0/1 | almost 4 years ago | $710 43.65% upside | $589.63 | TheFly | Previous targets (0) |
David Toung Argus Research | 100% 1/1 | about 4 years ago | $600 21.39% upside | $538.11 | TheFly | Previous targets (0) |
Thermo Fisher Scientific Financial Estimates
Thermo Fisher Scientific Revenue Estimates
Thermo Fisher Scientific EBITDA Estimates
Thermo Fisher Scientific Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $39.21B N/A | $44.91B 14.54% | $42.85B -4.58% | Avg: $46.07B Low: $45.34B High: $46.56B avg. 7.51% | Avg: $49.52B Low: $48.88B High: $50.19B avg. 7.47% | Avg: $52.95B Low: $52.26B High: $53.66B avg. 6.92% | Avg: $53.85B Low: $53.15B High: $54.58B avg. 1.70% |
Net Income
% change YoY
| $7.72B N/A | $6.95B -10.03% | $5.99B -13.74% | Avg: $6.96B Low: $6.23B High: $7.93B avg. 16.12% | Avg: $8.04B Low: $7.85B High: $9.40B avg. 15.60% | Avg: $11.96B Low: $11.76B High: $12.17B avg. 48.65% | Avg: $13.96B Low: $13.73B High: $14.21B avg. 16.76% |
EBITDA
% change YoY
| $12.16B N/A | $12.05B -0.90% | $11.19B -7.14% | Avg: $12.94B Low: $12.73B High: $13.07B avg. 15.60% | Avg: $13.90B Low: $13.72B High: $14.09B avg. 7.47% | Avg: $14.87B Low: $14.67B High: $15.07B avg. 6.92% | Avg: $15.12B Low: $14.93B High: $15.33B avg. 1.70% |
EPS
% change YoY
| $19.61 N/A | $17.73 -9.58% | $15.53 -12.40% | Avg: $18.64 Low: $16.06 High: $20.45 avg. 20.01% | Avg: $21.77 Low: $20.24 High: $24.25 avg. 16.78% | Avg: $30.84 Low: $30.32 High: $31.38 avg. 41.66% | Avg: $36.01 Low: $35.4 High: $36.64 avg. 16.76% |
Operating Expenses
% change YoY
| $10.00B N/A | $10.99B 9.83% | $10.24B -6.84% | Avg: $7.91B Low: $7.78B High: $7.99B avg. -22.75% | Avg: $8.50B Low: $8.39B High: $8.61B avg. 7.47% | Avg: $9.09B Low: $8.97B High: $9.21B avg. 6.92% | Avg: $9.24B Low: $9.12B High: $9.37B avg. 1.70% |
FAQ
What is Thermo Fisher Scientific stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 24.28% in 2025-2028.
We have gathered data from 16 analysts. Their low estimate is 6.23B, average is 6.96B and high is 7.93B.
What is Thermo Fisher Scientific stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 5.90% in 2025-2028.
We have gathered data from 19 analysts. Their low revenue estimate is $45.34B, average is $46.07B and high is $46.56B.
What is Thermo Fisher Scientific stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 23.80% in 2025-2028.
We have gathered data from 16 analysts. Their low earnings per share estimate is $16.06, average is $18.64 and high is $20.45.
What is the best performing analyst?
In the last twelve months 7 analysts have been covering Thermo Fisher Scientific stock. The most successful analyst is Catherine Schulte.